Shares of NPS Pharmaceuticals (NPSP), up 8.8% premarket, gain back some ground lost over the last week after the company announces positive top-line results for a trial of its endocrine disorder treatment.
Sent to 3,304 people who get email alerts on NPSP.
Get email alerts on NPSP »
Want to be faster and smarter on all your stocks?
Upgrade all your basic real-time alerts to PRO Alerts, for $20.